A clinical study to study the drug INJI CHOORANAM on Cegana Vatham (Cervical Spondylosis)

A prospective open labeled randomized clinical trial on Cegana Vatham (Cervical Spondylosis) with evaluation of trial drug "Inji Chooranam "

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012711

Enrollment

Registered

2018-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cegana Vatham

Interventions

Intervention1: INJI Chooranam: 1g orally bd with warm water for 48 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient with appropriate symptoms of neck pain radiating to upper limb with or without numbness giddiness neck stiffness and restricted neck movements Willing for doing laboratory investigations and x Ray imaging Neck stability index score should be equal or greater than 60%

Exclusion criteria

Exclusion criteria: Extra cervical rib trauma Systemic hypertension Diabetes mellitus Chronic kidney disease Tuberculosis in spine Ischemic heart disease Pregnancy Lactating mother Neoplasams Patient with any other chronic illness Systemic illness Congenital spinal anomalies Malignancy secondaries

Design outcomes

Primary

Measure	Time frame
The therapeutic efficacy of trial drug Inji Chooranam on Cegana VathamTimepoint: 48 days	—

Secondary

Measure	Time frame
Evaluation of Siddha diagnostic parametersTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr A Manoharan

Government Siddha Medical college and hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026